Medinova Diagnostic Services
No trades in 1Y
Peer Comparison
Healthcare › Healthcare Services › Healthcare Service Provider
| ₹2,029.40 | 62.75 | ₹32,036 Cr | 13.58 | 0.26% | 22.30% | 28.00% | ₹2,891 Cr | ₹545 Cr | |
| ₹1,424.60 | 78.15 | ₹14,588 Cr | 15.33 | 0.14% | 18.30% | 20.50% | ₹857 Cr | ₹187 Cr | |
| ₹581.25 | 59.74 | ₹11,437 Cr | 8.03 | 0.88% | 13.60% | 17.80% | ₹1,710 Cr | ₹203 Cr | |
| ₹495.50 | 44.72 | ₹7,723 Cr | 14.25 | 2.90% | 28.40% | 35.40% | ₹876 Cr | ₹176 Cr | |
| ₹622.35 | 148.53 | ₹5,903 Cr | 5.61 | 0.00% | 8.83% | 15.30% | ₹1,053 Cr | ₹85 Cr | |
| ₹333.05 | 48.41 | ₹1,717 Cr | 7.08 | 0.15% | 14.20% | 17.30% | ₹325 Cr | ₹35 Cr | |
| ₹483.05 | 15.84 | ₹1,571 Cr | 1.51 | 0.41% | 10.90% | 12.70% | ₹726 Cr | ₹98 Cr | |
Medinova Diagnostic Services (this company) | — | — | — | — | — | — | 109.00% | ₹10 Cr | — |
| Median 8 companies | ₹581.25 | 59.74 | ₹7,723 Cr | 8.03 | 0.26% | 14.20% | 19.15% | ₹867 Cr | ₹176 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Key Insights
No strengths listed
Weaknesses
1- The company has delivered a poor sales growth of 5.66% over past five years.
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2025; 1Y: fiscal year to Mar 2025 against Mar 2024.
Revenue
| 10Y | +3.43% |
|---|---|
| 5Y | +5.66% |
| 3Y | −9.42% |
| 1Y | −3.54% |
Net profit
| 10Y | Turned to profit |
|---|---|
| 5Y | Turned to profit |
| 3Y | −7.23% |
| 1Y | −5.00% |
Operating cash flow
| 10Y | — |
|---|---|
| 5Y | +15.24% |
| 3Y | +23.13% |
| 1Y | −5.62% |
10Y: The statements do not go back far enough for this window.
Operating margin· change in pp
| 10Y | +78.05 pp |
|---|---|
| 5Y | +15.08 pp |
| 3Y | +2.78 pp |
| 1Y | +3.36 pp |
Trailing twelve months: The latest quarterly results are more than a year old.
Revenue by year
| Mar 2016 | ₹7.47 Cr |
|---|---|
| Mar 2017 | ₹7.79 Cr |
| Mar 2018 | ₹8.67 Cr |
| Mar 2019 | ₹8.97 Cr |
| Mar 2020 | ₹7.45 Cr |
| Mar 2021 | ₹12.74 Cr |
| Mar 2022 | ₹13.20 Cr |
| Mar 2023 | ₹9.99 Cr |
| Mar 2024 | ₹10.17 Cr |
| Mar 2025 | ₹9.81 Cr |
Net profit by year
| Mar 2016 | −₹2.07 Cr |
|---|---|
| Mar 2017 | −₹1.74 Cr |
| Mar 2018 | −₹0.45 Cr |
| Mar 2019 | ₹0.82 Cr |
| Mar 2020 | −₹0.23 Cr |
| Mar 2021 | ₹1.90 Cr |
| Mar 2022 | ₹2.38 Cr |
| Mar 2023 | ₹1.67 Cr |
| Mar 2024 | ₹2.00 Cr |
| Mar 2025 | ₹1.90 Cr |
Quarterly Results
₹ CrResults for the period ended Dec 2025 were due by 14 Feb 2026 and are not in this table yet.
| Particulars | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.56 | 2.22 | 2.75 | 2.42 | 2.87 | 2.39 | 2.49 | 2.49 | 2.56 | 2.25 | 2.51 | 2.72 | 2.5 |
| Expenses | 1.93 | 1.73 | 1.83 | 1.89 | 1.97 | 1.8 | 1.74 | 1.8 | 1.76 | 1.59 | 1.66 | 1.67 | 1.57 |
| Operating Profit | 0.63 | 0.49 | 0.92 | 0.53 | 0.9 | 0.59 | 0.75 | 0.69 | 0.8 | 0.66 | 0.85 | 1.05 | 0.93 |
| OPM % | 24.61% | 22.07% | 33.45% | 21.9% | 31.36% | 24.69% | 30.12% | 27.71% | 31.25% | 29.33% | 33.86% | 38.6% | 37.2% |
| Other Income | 0.03 | 0.01 | 0.16 | 0.02 | 0.02 | 0.03 | 0.13 | 0.02 | 0.03 | 0.03 | 0.07 | 0.06 | 0.03 |
| Interest | 0.16 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.12 | 0.13 | 0.13 | 0.12 | 0.12 | 0.11 |
| Depreciation | 0.1 | 0.08 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 |
| PBT | 0.4 | 0.28 | 0.9 | 0.38 | 0.75 | 0.45 | 0.71 | 0.56 | 0.66 | 0.52 | 0.76 | 0.95 | 0.82 |
| Tax % | 10% | 17.86% | 14.44% | 13.16% | 10.67% | 11.11% | 15.49% | 23.21% | 25.76% | 26.92% | 22.37% | 31.58% | 35.37% |
| Net Profit | 0.36 | 0.23 | 0.77 | 0.33 | 0.66 | 0.4 | 0.6 | 0.42 | 0.5 | 0.38 | 0.6 | 0.66 | 0.51 |
| EPS (₹) | 0.36 | 0.23 | 0.77 | 0.33 | 0.66 | 0.4 | 0.6 | 0.42 | 0.5 | 0.38 | 0.6 | 0.66 | 0.51 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7 | 7.47 | 7.79 | 8.67 | 8.97 | 7.45 | 12.74 | 13.2 | 9.99 | 10.17 | 9.81 | 9.98 |
| Expenses | 10.28 | 7.49 | 7.68 | 7.94 | 7.64 | 6.25 | 9.74 | 9.45 | 7.34 | 7.34 | 6.75 | 6.49 |
| Operating Profit | −3.28 | −0.02 | 0.11 | 0.73 | 1.33 | 1.2 | 3 | 3.75 | 2.65 | 2.83 | 3.06 | 3.49 |
| OPM % | −46.86% | −0.27% | 1.41% | 8.42% | 14.83% | 16.11% | 23.55% | 28.41% | 26.53% | 27.83% | 31.19% | 34.97% |
| Other Income | 0.33 | 0.17 | 1.77 | 1.48 | 1.7 | 0.07 | 0.14 | 0.15 | 0.23 | 0.2 | 0.12 | 0.19 |
| Interest | 0.23 | 0.52 | 1.06 | 0.84 | 0.66 | 0.59 | 0.46 | 0.56 | 0.65 | 0.62 | 0.54 | 0.48 |
| Depreciation | 1.03 | 1.92 | 2.66 | 1.88 | 1.29 | 0.95 | 0.72 | 0.55 | 0.33 | 0.13 | 0.14 | 0.15 |
| PBT | −4.21 | −2.29 | −1.84 | −0.51 | 1.08 | −0.27 | 1.96 | 2.79 | 1.9 | 2.28 | 2.5 | 3.05 |
| Tax % | −14.73% | −9.61% | −5.43% | −11.76% | 25% | −18.52% | 3.06% | 15.05% | 12.11% | 12.28% | 24% | — |
| Net Profit | −3.59 | −2.07 | −1.74 | −0.45 | 0.82 | −0.23 | 1.9 | 2.38 | 1.67 | 2 | 1.9 | 2.15 |
| EPS (₹) | −3.78 | −2 | −1.74 | −0.45 | 0.82 | −0.26 | 2.02 | 2.27 | 1.67 | 2 | 1.9 | 2.15 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.46 | 9.46 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 |
| Reserves | −16.24 | −18.14 | −19.52 | −19.66 | −18.87 | −19.13 | −17.15 | −16.77 | −15.09 | −13.08 | −11.2 | −10.04 |
| Borrowings | 1.89 | 8.9 | 8.45 | 7.26 | 6.43 | 5.64 | 4.47 | 6.38 | 5.75 | 5 | 5 | 4 |
| Other Liabilities | 15.27 | 12.59 | 9.7 | 8.51 | 7.25 | 7.59 | 7.1 | 4.87 | 3.86 | 3.5 | 3.17 | 3.7 |
| Total Liabilities | 10.38 | 12.81 | 8.59 | 6.07 | 4.77 | 4.06 | 4.38 | 4.44 | 4.48 | 5.38 | 6.93 | 7.62 |
| Fixed Assets | 6.54 | 9.24 | 6.89 | 4.48 | 3.34 | 2.4 | 1.87 | 1.49 | 1.55 | 1.64 | 1.94 | 1.88 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.51 | 2.28 |
| Other Assets | 3.84 | 3.57 | 1.7 | 1.59 | 1.43 | 1.66 | 2.51 | 2.95 | 2.93 | 3.74 | 3.48 | 3.46 |
| Total Assets | 10.38 | 12.81 | 8.59 | 6.07 | 4.77 | 4.06 | 4.38 | 4.44 | 4.48 | 5.38 | 6.93 | 7.62 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | −0.62 | 0.08 | 1.16 | 1.3 | 1.24 | 1.69 | 1.35 | 1.42 | 2.67 | 2.52 |
| Investing | — | −4.65 | −0.11 | 0.37 | −0.15 | −0.16 | −0.06 | −1.84 | −0.34 | −0.21 | −1.9 |
| Financing | — | 5.33 | −0.01 | −1.5 | −1.2 | −1.07 | −1.37 | 0.31 | −0.85 | −1.32 | −0.63 |
| Net Cash Flow | — | 0.06 | −0.04 | 0.04 | −0.06 | 0.01 | 0.25 | −0.17 | 0.23 | 1.14 | −0.01 |
| Free Cash Flow | — | −5.27 | −0.03 | 1.53 | 1.15 | 1.23 | 1.5 | 1.19 | 1.03 | 2.46 | 2.04 |
| CFO/OP | — | 3,100 | 73 | 159 | 123 | 106 | 56 | 49 | 57 | 98 | 93 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 37.54 | 22.48 | 14.53 | 8.84 | 19.12 | 17.15 | 23.78 | 14.38 | 25.58 | 15.43 | 20.46 |
| Inventory Days | 86.45 | 58.99 | 32.3 | — | — | — | — | — | — | — | — |
| Days Payable | 3,463 | 1,534 | 1,353 | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | −3,339 | −1,452 | −1,307 | 8.84 | 19.12 | 17.15 | 23.78 | 14.38 | 25.58 | 15.43 | 20.46 |
| Working Capital Days | −623 | −548 | −455 | −371 | −341 | −406 | −199 | −123 | −97.92 | −92.95 | −81.48 |
| ROCE % | — | — | — | — | — | — | — | — | 2684.21% | 232% | 108.87% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Medinova Diagnostic Services insights
58 extracted metrics across FY10–FY26.
Documents
Frequently Asked Questions about Medinova Diagnostic Services
What does Medinova Diagnostic Services Ltd do?
Which sector does Medinova Diagnostic Services Ltd belong to?
Company Information
Incorporated in 1985, Medinova Diagnostic Services Ltd is in the business of providing diagnostic services.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/246883.md for Medinova Diagnostic Services Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.